Primary Cutaneous Peripheral T-Cell Lymphoma NOS: Diagnostic Criteria and Challenges.
Robson A, Bakr F, Cabeçadas J.
Am J Dermatopathol. 2024 Jul 1;46(7):399-409. doi: 10.1097/DAD.0000000000002547. Epub 2023 Dec 13.
Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
Oluwasanjo A, Kartan S, Johnson W, Alpdogan O, Gru A, Mishra A, Haverkos BM, Gong J, Porcu P.
Cancer Treat Res. 2019;176:83-98. doi: 10.1007/978-3-319-99716-2_4.
International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project.
J Clin Oncol. 2008 Sep 1;26(25):4124-30. doi: 10.1200/JCO.2008.16.4558. Epub 2008 Jul 14.
Update on T-Cell Lymphoma Epidemiology.
Chen JJ, Tokumori FC, Del Guzzo C, Kim J, Ruan J.
Curr Hematol Malig Rep. 2024 Jun;19(3):93-103. doi: 10.1007/s11899-024-00727-w. Epub 2024 Mar 7.
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d'Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J.
Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19.
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.
Brink M, Huisman F, Meeuwes FO, van der Poel MWM, Kersten MJ, Wondergem M, Böhmer L, Woei-A-Jin FJSH, Visser O, Oostvogels R, Jansen PM, Diepstra A, Snijders TJF, Huls G, Vermaat JSP, Plattel WJ, Nijland M.
Blood Adv. 2024 Jul 23;8(14):3619-3628. doi: 10.1182/bloodadvances.2023012531.
Peripheral T-cell lymphoma-NOS in children and adolescents: a review from the Children's Oncology Group NHL Committee.
Devine KJ, Schwartz L, El-Mallawany NK.
Blood Adv. 2025 Mar 25;9(6):1420-1431. doi: 10.1182/bloodadvances.2024013689.
Genetic Landscape of Peripheral T-Cell Lymphoma.
Hathuc V, Kreisel F.
Life (Basel). 2022 Mar 11;12(3):410. doi: 10.3390/life12030410.
Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment.
Pileri SA, Tabanelli V, Fiori S, Calleri A, Melle F, Motta G, Lorenzini D, Tarella C, Derenzini E.
Cancers (Basel). 2021 Sep 9;13(18):4535. doi: 10.3390/cancers13184535.
Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma.
Atallah-Yunes SA, Robertson MJ, Davé UP.
Clin Lymphoma Myeloma Leuk. 2022 Sep;22(9):659-665. doi: 10.1016/j.clml.2022.04.015. Epub 2022 Apr 22.
